1. 5PSQ-092 Analysis of off-label uses of inhalers in hospitalised patients. (2nd March 2018) Authors: Villamañán, E; Freire, M; Sobrino, C; Jiménez, I; Lara, C; Ruano, M; Pérez, E; Jiménez, C; Rossignoli, A; Herrero, A Journal: European journal of hospital pharmacy Issue: Volume 25(2018)Supplement 1 Page Start: A207 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 6ER-023 The role of institutional review boards, and hospital pharmacists as members, in the informed consent process in clinical research: a retrospective observational study. (24th March 2020) Authors: Villamañán, E; Sobrino, C; Freire, M; Inmaculada, JN; Luis, SR; Patricia, L; Lara, C; Fernández De Uzquiano, E; Herrero, A; Moreno, M Journal: European journal of hospital pharmacy Issue: Volume 27(2020)Supplement 1 Page Start: A215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0173 Mycobacterial infection in systemic lupus erythematosus: clinical significance and associated factors. data from the registry of patients with sle of the spanish society of rheumatology (RELESSER). (15th June 2017) Authors: Pego-Reigosa, J; Campo, V; Lois-Iglesias, A; Mouriño, C; Lόpez-Longo, F; Galindo, M; Calvo, J; Ibañez, J; Olivé, A; Melero, R; FdezNebro, A; Bernal, J; Erausquin, C; Tomero, E; Horcada, L; Uriarte, E; Freire, M; Rua-Figueroa, I Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0576 Antineutrophilic cytoplasmic antibody-associated vasculitis: is hypocomplementemia a predictor of poor prognosis?. (15th June 2017) Authors: Estévez, M; Argibay, A; Rodriguez, L; Lorenzo, R; Freire, M; Vázquez-Triñanes, C; Villaverde, I; Gimena, B; Fernández-Martín, J; Rivera, A Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1252 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AB0624 Interstictial lung disease in scleroderma: severity associated factors. objetives. (15th June 2017) Authors: Cano, D Sanchez; Centeno, N Ortego; Moreno, MT Cruces; Comet, L Sáez; Freire, M; Todlí, JA Parra; Caballeira, M Rodríguez; Aznar, C Simeόn Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1270 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. AB0988 BehÇet's disease in a defined area of northwestern spain. (15th June 2017) Authors: Estévez, M; Argibay, A; Lorenzo, R; Freire, M; Fernandez-Martín, J; Gimena, B; Vázquez-Triñanes, C; Rivera, A Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1400 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. CP-005 Assessment of drug-drug interactions involving psychiatric agents in hospitalised patients. (24th March 2015) Authors: Freire, M; Sobrino, C; De Sebastián, M; Balade, L; Bravo, M; Lara, C; Villamañán, E; Herrero, A Journal: European journal of hospital pharmacy Issue: Volume 22(2015)Supplement 1 Page Start: A2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. CP-064 Effectiveness of new direct acting antivirals for chronic hepatitis C depending on genotype in real medical practice. (25th February 2017) Authors: Molina, M; Moreno, F; Jimenez, I; Gonzalez, A; Jimenez, C; Rossignoli, A; Freire, M; Herrero, A Journal: European journal of hospital pharmacy Issue: Volume 24(2017)Supplement 1 Page Start: A28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. DI-028 Reasons for changing treatment to oral agents in multiple sclerosis. (25th February 2017) Authors: Molina, M; Rodriguez, E; Gonzalez, A; Gonzalez, L; Moreno, F; Jimenez, I; Freire, M; Herrero, A Journal: European journal of hospital pharmacy Issue: Volume 24(2017)Supplement 1 Page Start: A125 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Differences in clinical manifestations and increased severity of systemic lupus erythematosus between two groups of Hispanics: European Caucasians versus Latin American mestizos (data from the RELESSER registry). (January 2020) Authors: Hernández Cruz, B; Alonso, F; Calvo Alén, J; Pego-Reigosa, J M; López-Longo, F J; Galindo-Izquierdo, M; Olivé, A; Tomero, E; Horcada, L; Uriarte, E; Erausquin, C; Sánchez-Atrio, A; Montilla, C; Santos Soler, G; Fernández-Nebro, A; Blanco, R; Rodríguez-Gómez, M; Vela, P; Freire, M; Díez-Álvarez, E Journal: Lupus Issue: Volume 29:Number 1(2020) Page Start: 27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗